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Both exposure of stratum corneum to neutral pH buf-
fers and blockade of acidi¢cation mechanisms disturb
cutaneous permeability barrier homeostasis and stra-
tum corneum integrity/cohesion, but these approaches
all introduce potentially confounding variables. To
study the consequences of stratum corneum neutraliza-
tion, independent of hydration, we applied two chemi-
cally unrelated superbases, 1,1,3,3-tetramethylguanidine
or 1,8-diazabicyclo [5,4,0] undec-7-ene, in propylene
glycol:ethanol (7:3) to hairless mouse skin and assessed
whether discrete pH changes alone regulate cutaneous
permeability barrier function and stratum corneum in-
tegrity/cohesion, as well as the responsible mechanisms.
Both 1,1,3,3-tetramethylguanidine and 1,8-diazabicyclo
[5,4,0] undec-7-ene applications increased skin surface
pH in parallel with abnormalities in both barrier home-
ostasis and stratum corneum integrity/cohesion. The
latter was attributable to rapid activation (o20 min)
of serine proteases, assessed by in situ zymography,
followed by serine-protease-mediated degradation of
corneodesmosomes.Western blotting revealed degrada-
tion of desmoglein 1, a key corneodesmosome structur-
al protein, in parallel with loss of corneodesmosomes.
Coapplication of serine protease inhibitors with the su-
perbase normalized stratum corneum integrity/cohe-
sion. The superbases also delayed permeability barrier
recovery, attributable to decreased b-glucocerebrosidase
activity, assessed zymographically, resulting in a lipid-
processing defect on electron microscopy. These studies
demonstrate unequivocally that stratum corneum neu-
tralization alone provokes stratum corneum functional
abnormalities, including aberrant permeability barrier
homeostasis and decreased stratum corneum integrity/
cohesion, as well as the mechanisms responsible for
these abnormalities. Key words: corneodesmosome/perme-
ability barrier function/serine protease/serine protease inhi-
bitor/stratum corneum/superbase/transepidermal water loss.
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A
lthough the skin has long been known to display an
acid surface (‘‘acid mantle’’) (Schade and Marchioni-
ni, 1928), even today little is known about either the
origin or the function(s) of this acidic surface. Prior
students of the acid mantle ascribed its origin prin-
cipally to exogenous sources, of microbial, sebaceous gland, and/
or eccrine gland origin (Marchionini and Hausknecht, 1938).
Furthermore, based upon a variety of indirect evidence, its func-
tion has been assumed to be principally antimicrobial (Aly et al,
1975; Puhvel et al, 1975).
Recent studies support alternative views of the origin of the
acid mantle, as well as additional functions of stratum corneum
(SC) acidity (Ohman and Vahlquist, 1994; 1998; Chikakane and
Takahashi, 1995; Denda et al, 2000). In addition to exogenous me-
chanisms, three endogenous pathways have been identi¢ed as po-
tential contributors to SC acidity: (1) generation of urocanic acid
by histidase-catalyzed deimination of histidine (Krien and Ker-
mici, 2000); (2) secretory phospholipase A2 (sPLA2) generation
of free fatty acids from phospholipids (Fluhr et al, 2001); and (3)
a nonenergy-dependent sodiumproton exchanger (NHE1)
(Behne et al, 2002). Of these three mechanisms, the histidase path-
way, though quantitatively capable of acidifying the SC (Krien
and Kermici, 2000), appears least likely to mediate functions in
the lower SC, because (1) lack of substrate would make this me-
chanism nonoperative at the high relative humidities of the stra-
tum compactum (Scott and Harding, 1986), and (2) urocanic acid
is a water-soluble metabolite, which may not reach lipophilic
membrane domains from the corneocyte cytosol, where it is gen-
erated. Yet, it is in membrane sites in the lower SC that the per-
meability barrier is formed (Elias and Friend, 1975), and it is in
these sites that SC integrity/cohesion localizes (Chapman and
Walsh, 1990; Fartasch et al, 1993; Elias et al, 2001). Hence, our la-
boratory has focused recently on the role and functional impor-
tance of the sPLA2 and NHE1 pathways, which both appear to
in£uence membrane acidity in the lower SC (Fluhr et al, 2001;
Behne et al, 2002). Indeed, inhibition and/or blockade of either
sPLA2 or NHE1 result in an elevated SC pH; and more impor-
tantly, interference with these mechanisms perturbs permeability
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barrier homeostasis and/or SC integrity/cohesion (Fluhr et al,
2001; Behne et al, 2002).
Direct evidence for the importance of pH for permeability
barrier homeostasis was ¢rst shown by the delay in barrier recov-
ery that occurs when acutely disrupted skin sites are immersed in
neutral pH bu¡ers (Mauro et al, 1998). Moreover, the barrier ab-
normality resulting from either sPLA2 or NHE1 blockade could
be overridden by coexposure of inhibitor-treated sites to an acidic
(normal pH) bu¡er (Fluhr et al, 2001; Behne et al, 2002). An acidic
pH is critical for barrier homeostasis, in part because two key li-
pid-processing enzymes, b-glucocerebrosidase (bGlcCer’ase) and
acidic sphingomyelinase, which generate a family of ceramides
from glucosylceramide and sphingomyelin precursors, respec-
tively (Uchida et al, 2002), exhibit low pH optima (Vaccaro et al,
1985; Holleran et al, 1993; Jensen et al, 1999; Schmuth et al, 2000). It
has also been proposed that an acidic pH directly impacts lipid^
lipid interactions in the SC extracellular lamellar bilayers (Bouw-
stra et al, 1999). Together, these mechanisms appear to regulate the
competence of the extracellular lamellar bilayer system.
An acidic SC pH also clearly promotes SC integrity and cohe-
sion. Exposure to either neutral pH bu¡ers or sPLA2 blockade
results in an enhanced tendency for the SC to be removed by tape
stripping (¼ integrity), as well as increased amounts of protein
removed per stripping (¼ cohesion) (Fluhr et al, 2001). In the case
of sPLA2 blockade, the alterations in SC integrity/cohesion could
be further attributed to a decreased density of corneodesmosomes
(CD), and to a decline in at least one of its constituent proteins,
desmoglein 1 (DSG1) (Fluhr et al, 2001). Furthermore, as both the
chymotryptic and tryptic serine proteases (SCCE and SCTE),
which mediate degradation leading to desquamation, exhibit
neutral pH optima (Ekholm et al, 2000), they could become acti-
vated as SC pH increases.
All prior attempts to manipulate SC pH, and to assess the ef-
fects of pH on epidermal function, have utilized either bu¡ers,
which could exert e¡ects on function independent of pH (e.g.,
from hydration or occlusion), or inhibitor/knockout models
(e.g., a variety of unrelated changes can occur). To establish de¢-
nitively the apparent link between SC pH and barrier homeosta-
sis and SC integrity/cohesion, we developed a new model in
which SC pH could be modulated directly, utilizing topical ap-
plications of low concentrations of two ‘‘superbases’’, 1,1,3,3-tetra-
methyl-guanidine (TMG) and 1,8-diazabicyclo [5,4,0] undec-7-
ene (DBU) (Kaljurand et al, 2000; Oyama and Kondo, 2003), to
raise and sustain pH to speci¢c levels within the SC, without evi-
dence of toxicity at the low concentrations employed. Because su-
perbases and superacids are by de¢nition at least an order of
magnitude more basic or more acidic than 1 N NaOH and 1 N
H2SO4 (DesMarteau, 2000; Oyama and Kondo, 2003), they can
be used to manipulate pH locally when applied in very low con-
centrations. In addition, their internal naphthalene structure
should favor absorption throughout the SC. Elevations of SC
pH utilizing this approach were accompanied by abnormalities
in both SC integrity/cohesion and permeability barrier homeos-
tasis, attributable to accelerated serine protease (SP) mediated de-
gradation of CD, and defects in lipid processing, respectively.
MATERIALS ANDMETHODS
Animals and materials Male hairless mice (Skh1/Hr), 6^8 wk old, were
purchased from Charles River Laboratories (Wilmington, MA) and fed
Purina mouse diet and water ad libitum. Propylene glycol, ethanol, and
HCl were from Fisher Scienti¢c (Fairlane, NJ), whereas TMG, DBU,
phenylmethylsulfonyl £uoride (PMSF), chymostatin, soybean trypsin
inhibitor, and aprotinin were from Sigma Chemical (St Louis, MO).
Rabbit polyclonal antibody against mouse DSG1was a gift from Dr John
Stanley (University of Pennsylvania). Horseradish peroxidase conjugated
with antirabbit IgG was purchased fromVector Laboratories (Burlingame,
CA). EnzChek Protease Assay Kit, green £uorescence, and resoru¢n-D-
glucopyranoside were purchased from Molecular Probes (Eugene, OR).
22 mm D-Squame-100 tapes were purchased from CuDerm (Dallas, TX).
Bradford protein assay kit and bovine plasma g globulin were purchased
from Bio-Rad (Hercules, CA). Mice were anesthetized with chloral
hydrate (Morton Grove Pharmaceuticals, Morton Grove, IL).
Experimental procedures
Acute neutralization and pH recovery model Normal hairless mice were treated
topically with a single application of either TMG or DBU (dose range
1:100^1:1000 vol/vol) in propylene glycol:ethanol (7:3 vol/vol) on 5^6 cm2
areas on both £anks. Controls were treated with HCl-neutralized TMG
(nTMG) in the same propylene glycol:ethanol vehicle. The general idea of
using superbases is related to their ability to accept protons, thereby acting
as ‘‘proton sponges’’. The chelating function of superbasic TMG is based on
its 1,8-diaminonaphthalene skeleton. TMG not only shows a high thermo-
dynamic basicity (pKBHþ value of 25.1), but it also reveals unusually high
kinetics for basic reactions, which makes this superbase highly attractive for
base-catalyzed applications. Superbases such asTMG and DBU break water
to generate a hydroxyl group and chelate a proton to become positively
charged. As noted above, the positively charged superbase, with its lipid-
soluble core structure, confers onTMG and DBU physicochemical proper-
ties that allow penetration through the SC.
Surface pH was measured with a £at, glass surface electrode from Met-
tler-Toledo (Giessen, Germany), attached to a pH meter (PH 900; Courage
& Khazaka, Cologne, Germany), immediately before and at 1, 2, 4, 6, 9, 12,
18, and 24 h after TMG, DBU, and nTMG applications. For the experi-
ments with serine protease inhibitors (SPI), animals received coapplications
of TMG or DBU with either 10 mM PMSF, chymostatin, aprotinin,
or soybean trypsin inhibitor (concentrations speci¢ed in the legend
toTable I).
Post-barrier disruption, neutralization model Normal hairless mice were treated
topically with a single application of TMG (1:100 vol/vol) in propylene gly-
col:ethanol (7:3 vol/vol) on a 5^6 cm2 area on one £ank versus nTMG,TMG
plus PMSF, or vehicle alone to the contralateral £ank, or to the £anks of
littermates, immediately after barrier disruption by sequential tape strip-
ping (transepidermal water loss (TEWL) ratesX4 mg per cm2 per h). Sur-
face pH was measured immediately after disruption and at the same time
points as above, followed by assessment of function and mechanistic studies
(see below).
Functional assessments
Permeability recovery To assess the kinetics of epidermal permeability barrier
recovery,TEWL levels were measured on the £anks of hairless mice using
an electrolytic water analyzer (MEECO,Warrington, PA), immediately be-
fore and after, as well as 3 h after, acute barrier disruption by repeated D-
Squame tape stripping, and after a single application of TMG, nTMG,
DBU, or nDBU (see above).
SC hydration SC water content, as the sum of hydration of all SC layers,
was determined by capacitance measurements with a corneometer
(CM820, Courage & Khazaka, Cologne, Germany) 3 h after application
of TMG, nTMG, DBU, or nDBU to intact skin.
SC integrity To study SC integrity (rate of change inTEWLwith repeated
strippings), sequential tape stripping was performed on the £anks of hair-
less mice 3 h after prior application of either TMG or nTMG.TEWL levels
were measured after each tape stripping, until TEWL rates exceeded 4 mg
per cm2 per h (¢ve to six strippings in normal murine SC).
Table I. SPI reverse superbase-induced abnormalities in SC
integritya
Experimental group Integrity
(g per m2 per h7SD)
Signi¢cance
(p-value)
nTMG control 44.0075.56 o0.01
TMG alone 66.0074.35 
TMGþ soybean trypsin inhibitor 33.0074.58 o0.05
TMGþ aprotinin 19.3379.07 o0.01
TMGþ chymostatin 31.6675.85 o0.05
TMGþPMSF 20.50730.50 o0.01
aSC integrity was assessed 3 h after applications of TMG (1%) 7SPI (soybean
trypsin inhibitor, 0.5%; aprotonin, 2 mg per ml; chymostatin, 10 mM; or PMSF,
10 mM) coapplications to intact skin. Integrity re£ected TEWL levels after the
initial four D-Squame strippings in each animal (n¼ 4^6). All of the SPI signi¢-
cantly enhanced SC integrity. Results shown are the mean7SD.
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SC cohesion Three hours after superbase applications, and immediately be-
fore stripping the SC, the skin surface was cleaned with a single ethanol
wipe. D-Squame tapes were then placed sequentially onto the test areas
for about 3 s each, removed with forceps, and stored in glass scintillation
vials at 51C. SC cohesion is re£ected by the amount of protein removed
from pooled, sequential D-Squame strippings (whole SC down to the stra-
tum compactum from one site per mouse), extracted in 2 ml of 1 N
NaOH, and measured as previously described (Dreher et al, 1998). This mi-
croassay system was shown again to be linear for human SC in the
range 1^10 mg per ml, using SC from human callus to generate standard
curves (calculated slope Rf7SD is 0.029770.00062; Spearman coe⁄cient
0.999; po0.0001). The protein content per stripping was determined with
the Bio-Rad Protein Assay Kit, as described recently, using bovine g glo-
bulin as the standard in all assays (Fluhr et al, 2001). Brie£y, tapes were in-
cubated with 1ml of 1N NaOH for 1 h at 371C in an incubator shaker and
neutralized thereafter with 1 ml of 1 N HCl in the scintillation vials. Sub-
sequently, 0.2 ml of this solution was incubated in 0.6 ml distilled water
plus 0.2 ml of the Bio-Rad protein dye for 5 min in borosilicate tubes.
After incubations, the reagents were transferred to polystyrene cuvettes,
and absorption was measured with a Genesys 5 spectrophotometer (Spec-
tronic, Rochester, NY) at 595 nm. Blank D-Squame tapes were processed
and assayed as a negative control. The amount of protein removed was
then normalized to skin surface area (mg per cm2). The amount
of removed protein per D-Squame strip was comparable to previous
reports in untreated skin of hairless mice (i.e., range 2.5^4 mg per strip)
(Dreher et al, 1998).
In situ zymographic assays
SP activity Biopsies were obtained from hairless mouse £anks after
treatment with superbase or neutralized superbase, and the subcutaneous
fat was removed by scraping with a #10 Bard-Parker blade. Frozen
sections (10 mm thick) were rinsed with a washing solution (2% Tween
20 in deionized water) and incubated at 371C for 2 h with 250 ml of BOD-
IPY-Fl-casein in deionized water (2 ml per ml). To obtain en face views har-
vested skin was placed in a chamber slide system with the SC facing
toward the beam. Some superbase-treated sections were exposed to the
£uorophore substrate in an acidic bu¡er (10 mM Z-[N-morpholino] etha-
nesulfonic acid (MES) bu¡er, pH 5.5). All sections were rinsed with the
washing solution, counterstained with propidium iodide, mounted, and
visualized directly in a confocal microscope (Leica TCS SP, Heidelberg,
Germany) at an excitation wavelength of 485 nm and an emission wave-
length of 530 nm.
b-GlcCer’ase activity Biopsies were obtained from treated sites as above,
sectioned (6 mm), rinsed with the washing solution, and incubated with
250 ml of resoru¢n b-D-glucopyranoside in deionized water (1 mM) at
371C for 2 h. Acidi¢cation of some superbase-treated sections was again
performed with 10 mM MES bu¡er, pH to 5.5, as above. Sections were
then visualized in the confocal microscope at an excitation wavelength of
588 nm and an emission wavelength of 644 nm.
Western immunoblotting SC was isolated from hairless mouse £anks,
previously treated as above, using D-Squame sequential tape strippings
until no further SC could be removed (¼whole SC; typically ¢ve to six
strippings). Hematoxylin and eosin staining was performed on para⁄n
sections (6 mm) from biopsies of the tape-stripped areas to ensure
equivalent SC removal for each experiment group. D-Squame tapes were
then incubated overnight at 41C in 1% Triton X and a protease inhibitor
cocktail (Complete Mini, EDTA-Free, Roche, 1 tablet per 10 ml) in
deionized water and sonicated for 5 min at room temperature to extract
protein from the tapes. The protein content per stripping was then
determined, as above. An equal amount of extracted protein from
each experimental group was loaded onto 4%^12% Trisglycine
polyacrylamide gels (PAGE Gold Precast Gels, BioWhittaker Molecular
Applications, Rockland, ME). After electrophoresis, proteins were
transferred from slab gels onto nitrocellulose membranes and
immunoblotted with the rabbit antimouse DSG1 antibody, and antibody
binding to DSG1 was detected with the Western Lighting
chemiluminescence kit (PerkinElmer Life Sciences, Boston, MA).
Electron microscopy Skin biopsy samples were taken at 1 and 3 h after
the various treatments (n¼ 3 from each group) and processed for light and
electron microscopy. Samples were minced to less than 0.5 mm3, ¢xed in
modi¢ed Karnovsky’s ¢xative overnight, and post¢xed in either
ruthenium tetroxide (RuO4) or 2% aqueous osmium tetroxide (OsO4),
both containing 1.5% potassium ferrocyanide (Hou et al, 1991). After
post¢xation, all samples were dehydrated in graded ethanol solutions and
embedded in an Epon epoxy mixture. Ultrathin sections were examined,
with or without further lead citrate contrasting, in a Zeiss 10A electron
microscope (Carl Zeiss, Thornwood, NY), operated at 60 kV. In order to
quantify CD density in electron micrographs, 10 or more pictures were
taken by an independent observer from three or more blocks from three
animals in each experiment at 31,500 magni¢cation; i.e., a total of at least
30 micrographs. The ratio of the total length of intact CD to the total
length of the corni¢ed envelopes in the ¢rst and second cell layers of the
lower SC was determined using a planimeter (Morris, 2000).
Figure1. Single topical applications of two superbases acutely increase SC pH. (A), (B) BothTMG and DBU 1:100 in propylene glycol:ethanol, 7:3
vol/vol, increase SC pH. (C) The coapplication of an SPI (PMSF) did not prevent the TMG-induced increase in SC pH. (D) pH dose^response curve 3 h
after TMG applications at concentrations from 1:100 to 1:1000 vol/vol. (E) Surface pH recovers to normal values by 24 h following applications of TMG
(1:100). (E), (F) TheTMG-related increase in SC pH is sustainable and extends throughout the depth of the SC, with a signi¢cant increase in comparison to
nTMG-treated sites at all levels of the SC. Results shown represent mean7SD (n¼ 4^6 animals in each group).
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Statistical analyses Nonparametric Mann^Whitney statistical analyses
were performed to compare percentage ratios between di¡erent groups of
treatments (Morris, 2000). Statistical analyses were performed using Prism
2 (GraphPad Software, San Diego, CA)
RESULTS
Superbase applications increase SC pH without altering
epidermal morphology or basal barrier function Before
assessing the consequences of increased pH on SC function,
we ¢rst measured SC pH after applications of two chemically
unrelated superbases, TMG and DBU. Surface pH of hairless
mouse skin, assessed 3 h after a single TMG or DBU application,
increased signi¢cantly in comparison to nTMG and nDBU,
respectively (Fig 1AC). The changes in skin surface pH were
concentration dependent at TMG concentrations between 1:100
and 1:1000 (vol/vol) (Fig 1D), and regardless of applied dose,
recovery of an acidic surface pH occurred over the subsequent
24 h (Fig 1E). The superbase-induced increase in pH extended
throughout the SC, with pH in TMG-treated sites deep within
the SC remaining signi¢cantly higher than the pH at
comparable depths of nTMG-treated sites (Fig 1F).
Despite the sustained elevations in surface pH, histologic
sections, taken 3 and 24 h following TMG or nTMG treatment,
revealed neither histologic abnormalities nor evidence of
cytotoxicity or in£ammation (Fig 2). Moreover, despite the
sustained elevation in SC pH, both basal TEWL and SC
hydration levels remained unchanged in superbase-treated sites.
TEWL levels for TMG and DBU (1:100) remained around 2 mg
per cm2 per h (controls: 2.2 mg per cm2 per h), whereas hydration
levels in all groups remained between 31.5 and 36.8 (arbitrary
units). These studies show that a single application of a topical
superbase raises SC pH, in a sustainable and concentration-
dependent manner, extending throughout the SC. Moreover,
such superbase treatment does not produce evidence of toxicity
or in£ammation. Finally, such short-term increases in SC pH
alter neither basal TEWL nor SC hydration.
A neutral pH provokes abnormalities in SC integrity and
cohesion, attributable to SP activation To assess superbase-
associated changes in SC function, we ¢rst assessed the e¡ects of
a short-term elevation in pH on SC integrity and cohesion. After
3 h exposure of normal skin to either TMG or DBU, both SC
integrity and cohesion deteriorated signi¢cantly in comparison
to untreated skin (Fig 3). Moreover, the 1:100 and 1:1000
concentrations appeared to be equally e¡ective in producing
these alterations. Integrity and cohesion in acidi¢ed nTMG- or
nDBU-treated sites remained comparable to untreated skin
(Fig 3; untreated skin not shown).
Prior studies have shown that SC desquamation is mediated by
two SP, the SCCE and SCTE, which both exhibit neutral pH
Figure 2. Superbase treatment produces neither toxicity nor in-
£ammation. Hematoxylin and eosin stained para⁄n sections (6 mM) of
biopsies at 3 and 24 h after TMG (1%) and nTMG (1%) application show
comparable, normal cellular and epithelial structure, without evidence of
in£ammation or cytotoxicity. Magni¢cation bars: 10 mm.
Figure 3. Both superbases produce abnormalities in SC integrity and cohesion. SC integrity (A, B, C) and cohesion (D, E, F) 3 h after a single
application of either TMG or DBU versus nTMG or nDBU (1:100 or 1:1000 vol/vol) to intact skin. Integrity re£ects the rate of change of TEWLwith each
stripping. Cohesion re£ects the total protein removed from pooled D-Squame strippings taken from each treatment site. Results are shown as the
mean7SD (n¼ 4^6 animals in each group).
348 HACHEM ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
optima (Ekholm et al, 2000). To assess the basis for the pH-
induced changes in integrity and cohesion, we next assessed
whether SC neutralization alone (surface pH 7.4) activates SP,
evaluated by in situ zymography of SP activity in sections from
TMG- versus nTMG-treated skin sites. The increase in SP
activity could be detected as early as 20 min after superbase
applications, and remained elevated for at least 3 h (Fig 4). We
next ascertained whether the superbase-induced increases in SP
activation were reversible, with re-acidi¢cation of sections from
TMG-treated skin sites. As shown in Fig 5, SP activity
disappeared when the SC was re-acidi¢ed in an acidic (MES)
bu¡er, evidence that the superbase-induced increase in SP
activity re£ects pH-related modulations in enzyme catalytic
activity.
Finally, to determine whether the superbase-induced increases
in SP activity account for the observed abnormalities in SC
integrity/cohesion, we next assessed these functions when
superbase-treated sites were cotreated with an SPI (Fig 4). All of
the SPIs tested inhibited superbase-induced SP activation
(Fig 4D, F). The abnormalities in SC integrity and cohesion
were reversed by coapplications of PMSF (Fig 6) or several
other tryptic and/or chymotryptic SPI, including soybean
trypsin inhibitor, aprotinin, and chymostatin (Table I).
Similarly, abnormalities in SC cohesion were reversed when
PMSF was coapplied with TMG (data not shown). Yet, as shown
in Fig 1(C), coapplication of the SPIs did not themselves alter
surface pH; i.e. the superbase induced an increase in SC pH even
in the presence of an SPI. Together, these results show ¢rst, that a
superbase-induced increase in SC pH alters SC integrity and
cohesion; and second, that these functional changes are due to
reversible increases in SP activity.
Superbase-induced abnormalities in SC integrity/cohesion
correlate with accelerated CD degradation We next assessed
the structural basis for the abnormalities in SC integrity and
cohesion that result from SC neutralization. A single application
of TMG again induced an increase in SC pH (to 7.4), which, in
turn, provoked a signi¢cant decrease in the density of CD in the
lower SC, assessed by quantitative electron microscopy (Fig 6).
This decrease in CD density could be observed as early as 1 h after
Figure 4. The superbase-induced increase in SP activity is inhibited by coapplied SPI. (A)(C) In situ zymography of changes in SP activity 20
min, 1 h, and 3 h after superbase treatment demonstrates a progressive increase in enzyme activity in TMG- but not in nTMG-treated sites (D). (E), (F)
Coapplication of two chemically unrelated SPI (soybean trypsin inhibitor and PMSF) withTMG inhibits superbase-induced SP activation. En face views of
SC show SP activity to be localized to SC membrane domains (A versus D, insets). Magni¢cation bars: 10 mm.
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superbase applications (Fig 6). In contrast, nTMG applications
did not change CD density in comparison to untreated
SC (untreated data not shown). Furthermore, the decrease
in CD could be further ascribed to the superbase-induced
increase in SP activity (see above), because coapplications of
PMSF with TMG conserved CD density (Fig 6). Finally,
we assessed whether the superbase-induced decrease in CD
density was attributable to loss of its constituent proteins, by
assessing DSG1 in western blots of SC from TMG-, nTMG-,
and (TMGþPMSF)-treated SC. Immunoblotting showed
extensive proteolysis of DSG1 3 h after TMG treatment in
comparison to either nTMG or (TMGþPMSF)-treated samples
(Fig 7). Together, these results show that the decline
in SC integrity and cohesion at a neutral pH can be ascribed
to a rapid dissolution of CD and its constituent proteins in
the lower SC.
Elevation of SC pH delays barrier recovery after acute
insults Although exposure of intact skin to a neutral pH does
not alter basal permeability barrier function, prior studies
have shown that barrier recovery is delayed when acutely
disrupted skin sites are immersed in a variety of neutral pH
bu¡ers (Mauro et al, 1998). To determine whether SC
neutralization alone is responsible for the delay in the kinetics
of recovery after acute barrier disruption, we next applied
TMG immediately after acute barrier disruption by sequential
tape stripping, and assessed TEWL between 0 and 6 h after
disruption. At the 3 h time point, superbase (TMG) treated sites
exhibited a signi¢cant delay in barrier recovery (11.48%71.49%;
po0.01) in comparison to nTMG-treated sites (40.00%72.45%).
PMSF coapplications with TMG did not reverse the superbase-
induced delay in barrier recovery. However, (13.68%71.48%;
po0.01).
To explore the mechanism(s) responsible for the delay in
barrier recovery, we next assessed the in situ activity of a key
lipid-processing enzyme, b-GlcCer’ase, with an acidic pH
optimum, in TMG- versus nTMG-treated skin. b-GlcCer’ase
activity, assessed by in situ zymography, decreased markedly in
superbase-treated skin sites. To ascertain whether the elevation in
pH was a¡ecting enzyme activity, rather than inducing enzyme
degradation, we next assessed whether b-GlcCer’ase activity
reappeared with re-acidi¢cation of sections from TMG-treated
skin, as above. As seen in Fig 8, b-GlcCer’ase activity returned
when sections from superbase-treated skin were re-acidi¢ed (cf.
Fig 5, where re-acidi¢cation produced the opposite e¡ect; i.e.,
SP activity disappeared with re-acidi¢cation). Finally, TMG-
treated sites exhibited a delay in lipid processing, as indicated by
the persistence of ‘‘immature’’, partially processed, membrane
structures within the interstices of the lower SC (Fig 9). These
results show that the neutral-pH-induced delay in barrier
recovery can be attributed to a downregulation of at least one
lipid-processing enzyme (b-GlcCer’ase), which in turn results in
defective lipid processing leading to a corresponding delay in
maturation of SC membrane structures.
DISCUSSION
The skin has long been known to have an acidic surface that is
thought to play a key role in preventing infection (Wilhelm and
Maibach, 1990). In this paper, we demonstrate directly that acidi-
¢cation of the SC is important for at least two other essential
functions of mammalian skin. Using two unrelated superbases
that raise pH selectively within the SC without evidence of toxi-
city or in£ammation, we demonstrated that both cutaneous per-
meability barrier homeostasis and SC integrity and cohesion are
perturbed when SC pH is elevated. These results con¢rm and ex-
tend previous studies from our laboratory that employed less spe-
ci¢c methods to increase SC pH (Mauro et al, 1998; Fluhr et al,
2001; Behne et al, 2002) (Fig 10). Speci¢cally, in these prior
Figure 5. In situ SP activation is pH dependent. In situ acidi¢cation of
sections fromTMG-treated skin sections with MES bu¡er reverses SP ac-
tivation (B versus A). Bars: 10 mm.
Figure 6. The decline in CD density after SC neutralization is re-
versed by an SPI. Quantitative electron microscopy analysis for CD den-
sity shows a signi¢cant decline in CD density as early as 1 h after superbase
(TMG) applications, with a further decline by 3 h after superbase applica-
tions. CD density normalizes in superbase-treated skin with 3 h coapplica-
tions of an SPI, PMSF, withTMG.The ratio between the length of the CD
and the total length of the ¢rst SC cell layer was determined using a pla-
nimeter and converted to percentage. Results shown are the mean7SD
(n¼ 4^6 for each experimental group).
Figure 7. Superbase-induced degradation of DSG1 is reversed by a
coapplied SPI. Protein extracts from SC (n¼ 2 in each group) were
loaded onto Trisglycine polyacrylamide gels, and after transfer onto ni-
trocellulose membrane incubated further with DSG1 antibody at 41C over-
night. Blots show a decrease in DSG1 staining in TMG- versus nTMG-
treated SC, and skin treated with TMG plus the SPI, PMSF.
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studies, we (1) increased SC pH by immersion in a bu¡er solu-
tion, but this method would also inevitably increase SC hydra-
tion and occlusion (Mauro et al, 1998); (2) used inhibitors of
either sPLA2 (Fluhr et al, 2001) or NHE1 (Behne et al, 2002) that
raise SC pH, but inhibitors can produce a variety of unrelated or
toxic e¡ects; and (3) used transgenic knockout of NHE1 (Behne
et al, 2002), which could provoke other unrelated downstream al-
terations. For example, inhibition of sPLA2 perturbs cutaneous
permeability barrier function, independent of its e¡ects on SC
pH, by reducing the metabolism of phospholipids to free fatty
acids, which are required to form normal, extracellular lamellar
membranes (Mao-Qiang et al, 1995; 1996). Although elevation of
pH with bu¡ers was shown to increase colonization by patho-
genic bacteria, pH e¡ects could not be separated from e¡ects of
hydration and/or occlusion (Aly et al, 1975). Thus, the use of su-
perbases, as employed here, to raise SC pH directly avoids the po-
tential pitfalls of other methods to elevate pH experimentally, as
used by our and other laboratories.
In contrast, the superbase-induced increase in SC pH (1) was
dose dependent; (2) a¡ected all layers of the SC; (3) was reversible
with acidic bu¡ers; and (4) returned towards normal with time.
Yet, pH remained elevated for 6^12 h following a single superb-
ase application. Moreover, superbase treatment did not result in
any skin abnormalities, either on inspection or on morphologic
(light and electron microscopy) examination.The lack of toxicity
is also shown by the rapid reversibility of the superbase-induced
alterations by re-acidi¢cation and by the fact that the same mole-
cules, when neutralized (acidi¢ed), produce no functional or
structural abnormalities. Nor did the superbases alter SC hydra-
tion or basal permeability barrier function. Thus, the use of su-
perbases to elevate SC pH represents a direct, apparently
nontoxic approach to determine the e¡ects of alterations of SC
pH on cutaneous function. The results of this study, using su-
perbases to raise SC pH, together with previous studies that
raised pH with bu¡ers, inhibitors, or transgenic knockout ani-
mals, demonstrate clearly that an acidic SC pH is essential for
both normal permeability barrier function and SC integrity/
cohesion.
This study also shed light on the mechanisms by which an
acute increase in SC pH adversely impacts SC function. Several
types of protease activity have been identi¢ed in the SC (Hori-
koshi et al, 1999;Watkinson, 1999), with a convincing link to des-
quamation for two SP  SCCE and SCTE  based upon in vitro
inhibitor studies (Brattsand and Egelrud, 1999; Horikoshi et al,
1999). SCCE is localized to the extracellular membrane domains,
and delivered to the SC interstices via lamellar body secretion
(Hansson et al, 1994; Sondell et al, 1994). SCTE is distributed both
intracellularly and extracellularly within the SC (Watkinson et al,
1994; Ekholm et al, 2000). As both of these SP are most active at a
neutral pH (Brattsand and Egelrud, 1999; Ekholm and Egelrud,
2000), we postulate that the normal acidic environment of the
SC would reduce the catalytic activity of these enzymes, and con-
versely, an increase in SC pH would increase SP activity. In sup-
port of this hypothesis, we demonstrated here that raising SC pH
increased SP activity in membrane domains of the SC, and that
this increase in activity was reversible with lowering of SC pH.
Zymography in tissue sections provides information about
changes in total catalytic activity and about the localization of
such pH-induced changes. Furthermore, the superbase-induced
increase in SP activity led to an increased degradation of the
Figure 8. The delay in barrier recovery in neutralized SC is attribu-
table to reversible inactivation of a key lipid-processing enzyme. In
situ zymography shows a decrease in b-GlcCer’ase activity in skin sections
taken fromTMG-treated skin immediately following acute barrier disrup-
tion by tape stripping (B versus A). The decrease in enzyme activity is rever-
sible by re-acidi¢cation (C) but not by a coapplied SPI (PMSF).
Magni¢cation bars: 10 mm.
Figure 9. Superbase-induced delay in barrier recovery is attributa-
ble to abnormal lipid processing. (A) When either nTMG or vehicle
alone (Veh) are applied immediately after tape stripping (TS) of normal
skin, mature lamellar bilayers begin to appear at and just above the stratum
granulosumSC interface (A, open white arrows). (B) In TMG (superbase)
treated sites, incompletely processed lamellar membranes (solid arrows) per-
sist two to three cell layers above the stratum granulosum^SC interface.
(A), (B) RuO4 post¢xation. Magni¢cation bars: 0.25 mm. SB, superbase
(TMG) treated.
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proteins that form the CD, i.e., a reduction in DSG1, resulting in
a reduction in CD density and hence, in abnormal SC integrity
and cohesion (Fig 10). Most importantly, inhibition of SP activ-
ity with several di¡erent SPI prevented this cascade of events; i.e.,
DSG1 levels did not decline; CD density was maintained; and SC
integrity and cohesion remained normal, even in the face of an
increase in SC pH.
Although the above sequence of events, initiated by a pH-in-
duced increase in SP activity in the SC, explains why an elevation
in SC pH produces an abnormality in SC integrity and cohesion,
it does not explain the superbase-induced abnormality in cuta-
neous permeability barrier function. In contrast to SC integrity
and cohesion, SPI did not correct the defect in barrier homeosta-
sis induced by neutralization of the SC. Prior studies by our la-
boratory have demonstrated that processing of lipids secreted by
lamellar bodies in the extracellular spaces of the SC is essential for
the formation of mature lamellar membranes and normal perme-
ability barrier function (Rassner et al, 1999). Moreover, two of the
enzymes that are responsible for this lipid processing, b-GlcCer’-
ase, which hydrolyzes glucosylceramides to ceramides, and acid
sphingomyelinase, which hydrolyzes sphingomyelin to cera-
mides, are most active at an acidic pH (Vaccaro et al, 1985; Holler-
an et al, 1993; Jensen et al, 1999). Hence, the increased pH of the SC
would be expected to reduce the activity of these two key lipid-
processing enzymes, leading to a failure to form functionally
competent, lamellar bilayers. In this study, we demonstrate that
the b-GlcCer’ase activity declined following acute superbase treat-
ment, and that this decrease in activity was reversible by re-acid-
i¢cation of the SC. Moreover, incompletely processed (immature)
lamellar membranes in the SC accompanied the superbase-in-
duced decrease in b-GlcCer’ase activity. pH-linked changes in
processing enzyme activity have been observed previously in
other models (Mauro et al, 1998; Fluhr et al, 2001). Together, these
studies strongly suggest that an acute increase in SC pH reduces
the activity of certain key lipid-processing enzymes in the SC,
resulting in abnormal lipid processing and the formation of de-
fective lamellar membranes (Fig 10). Thus, although the speci¢c
pathways are di¡erent, the abnormalities in both SC integrity
and cohesion and permeability barrier function can be traced to
pH-induced modulations in enzyme activity in the SC. Although
an increase in SC pH can increase the activity of certain enzymes
(e.g., SP), it could simultaneously decrease the activity of other
enzymes (e.g., b-GlcCer’ase and acid sphingomyelinase) ( Jensen
et al, 1999; Schmuth et al, 2000). Studies over the last two decades
have shown that the SC is not an inert tissue, but rather that it
contains numerous enzymes and ongoing metabolic activities
that participate in the formation and shedding of the SC and that,
in turn, regulate the function of deeper skin layers (Elias et al,
1998; 1999). As the normal environment of the SC is acidic, it is
not surprising that an increase in the pH of the SC can lead to
functional abnormalities. Although our studies have elucidated
two such pathways (Fig 10), it is very likely that the activity of
other proteins/enzymes in the SC will be altered by increases in
SC pH, and that such increases will initiate other, as yet unde-
¢ned, functional abnormalities either in the SC or within deeper
skin layers.
The harmful e¡ects of an elevation in SC pH on cutaneous
function could adversely impact a number of clinical situations.
First, it is well recognized that many cutaneous disorders, includ-
ing acute eczema, atopic dermatitis, and seborrheic dermatitis,
are associated with an increased SC pH (Wilhelm and Maibach,
1990; Chikakane and Takahashi, 1995; Rippke et al, 2002). The
increase in SC pH in these disorders, by adversely a¡ecting
permeability barrier function and disrupting SC integrity and
cohesion, could further exacerbate these conditions, resulting in
more severe and/or more prolonged clinical manifestations. For
example, a pH-induced decline in SC integrity and coadhesion
would further enhance the skin’s susceptibility to minor injuries,
e.g. with exposure to solvents, detergents, or mechanical forces.
Moreover, the pH-induced increase in barrier disruption, with
further impairment in permeability barrier repair, is likely to
have adverse clinical consequences (virtually all dermatoses exhi-
bit abnormal barrier function). Previous studies by our laboratory
and other laboratories have shown that disturbances in barrier
function stimulate the epidermal production of in£ammatory cy-
tokines, such as interleukin-1 a/b and tumor necrosis factor a,
which could lead to or exacerbate in£ammation (Tsai et al, 1994;
Wood et al, 1996). A second important clinical situation where an
elevation in SC pH occurs is in neonates. At birth, the pH of
the SC is elevated (Green et al, 1968), and normal acidi¢cation of
the SC is not achieved for several weeks to months postbirth
(Yosipovitch et al, 2000). During this period of development, an
increased SC pH could adversely a¡ect permeability barrier
homeostasis and SC integrity and cohesion. As described above,
such functional alterations could have adverse clinical conse-
quences, and could contribute to the increased sensitivity of
neonates to the development of dermatitis. Diaper dermatitis is
an extremely common occurrence, and our studies support the
hypotheses that the elevated SC pH plays a role in increasing
the severity and duration of this disorder (Andersen et al, 1994;
Berg et al, 1994). Finally, our studies are relevant for the well-
known adverse e¡ects of alkaline soaps on the skin (reviewed in
Fluhr and Elias, 2002). Thus, our observations, which demon-
strate the importance of an acidic pH for two key SC functions,
could point to alternative preventive or therapeutic strategies for a
wide variety of cutaneous disorders that are associated with an
increase in SC pH.
These studies were supported by NIH grants AR 19098, 39448 (PP), HD 29706,
and the Medical Research Service, Department ofVeterans A¡airs.
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